Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]latest-news-updates/who-for-dengue-vaccine-in-india-sushmi-dey-4679898.html"/> LATEST NEWS UPDATES | WHO for dengue vaccine in India -Sushmi Dey | Im4change.org
Resource centre on India's rural distress
 
 

WHO for dengue vaccine in India -Sushmi Dey

-The Times of India

NEW DELHI: As dengue cases show a steep increase, particularly in Delhi, the World Health Organisation (WHO) has recommended introducing dengue vaccine in highburden countries like India.

Two months ago, the apex committee on health, headed by the health secretary, had denied approval to a multinational firm for its dengue vaccine when it sought a clinical trial waiver in India.

In May, the committee had concluded that the data presented by the company was inadequate to show the efficacy and immunogenicity of the vaccine in Indians. Immunogenicity is the ability of a substance to provoke an immune response in the body.

The government and the regulator are of the view that there is a need to test the vaccine on Indian patients.

Sources in the central drug regulator's office said data presented by the firm showed an efficacy rate of around 43%, against the requirement of 70%.

Please click here to read more.